Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Quest Diagnostics Raises 2025 Guidance


Diagnostic testing and information services provider Quest Diagnostics (NYSE:DGX) reported fiscal 2025 second-quarter results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 revenue hit $2.76 billion and adjusted earnings per share (EPS) came in at $2.62. These results reflect improvements across sales, margins, and operating income, with management raising its outlook for both revenue and adjusted diluted EPS.

The quarter showed a strong contribution from acquisitions, balanced by modest organic volume growth and slight pressure on revenue per requisition.

Source: Quest Diagnostics. Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year. pp = percentage points.

Continue reading


Source Fool.com

Like: 0
DGX
Share

Comments